You are here:

Category: 6.6 Drugs affecting bone metabolism

Name SMC ID No Manufacturer Status Sub. Type
 
alendronate colecalciferol (Fosavance) 213/05 MSD Superseded Abbreviated Submission
alendronic acid (Binosto) 1137/16 Internis Pharmaceuticals Ltd Restricted Abbreviated Submission
cinacalcet (Mimpara) 513/08 Amgen Ltd Not Recommended Non submission
denosumab (Prolia) 651/10 Amgen Ltd Restricted Full submission
denosumab (Prolia) 670/10 Amgen Ltd Not Recommended Non submission
denosumab (Xgeva) 752 /11 Amgen Ltd Superseded Non submission
denosumab (Xgeva) 1119/15 Amgen Ltd Not Recommended Non submission
Ibandronic acid (Bondronat®) 123/04 Roche Accepted Full submission
Ibandronic acid (Bondronat®) 122/04 Roche Accepted Full submission
Ibandronic acid (Bonviva®) 228/05 Roche Accepted Full submission
ibandronic acid, 3mg in 3ml solution for injection (Bonviva) 301/06 Roche Restricted Full submission
parathyroid hormone (Preotact) 356/07 Nycomed UK Ltd Marketing Authorisation Withdrawn Full submission
risedronate sodium (Actonel) 424/07 Procter and Gamble Not Recommended Non submission
Risedronate sodium (Actonel®) 46/03 Procter and Gamble Superseded Abbreviated Submission
strontium ranelate (Protelos) 816/12 Servier Laboratories Ltd Withdrawn Non submission
teriparatide (Forsteo) 490/08 Eli Lilly and Company Ltd Not Recommended Full submission
Teriparatide (Forsteo®) 71/03 Eli Lilly and Company Ltd Superseded Full submission
teriparatide 20 micrograms/80 microlitres, solution for injection, in prefilled pen (Forsteo) 487/08 Eli Lilly and Company Ltd Not Recommended Non submission
zoledronic acid (Aclasta) 535/08 Novartis Pharmaceuticals UK Ltd Not Recommended Non submission
zoledronic acid (Aclasta) 447/08 Novartis Pharmaceuticals UK Ltd Restricted Full submission
Zoledronic acid (Zometa®) 29/02 Novartis Pharmaceuticals UK Ltd Not Recommended IRP
Zoledronic acid (Zometa®) 29/02 Novartis Pharmaceuticals UK Ltd Not Recommended Full submission
Zoledronic acid (Zometa®) 29/02 Novartis Pharmaceuticals UK Ltd Restricted Resubmission
zoledronic acid 5mg/100ml solution for infusion (Aclasta) 317/06 Novartis Pharmaceuticals UK Ltd Accepted Full submission

Back